The Opioid Crisis : Potential Impact on Cancer Patients
“ There is nothing more important to me as a physician than your cancer treatment . I ’ ve been in practice for over two decades and have had the privilege of telling many patients that there is life beyond cancer . As president of The Center for Cancer and Blood Disorders , I want to lead by example , practicing a firm belief that all patients should receive the finest medical care available , with the same concern and compassion as a cherished member of the family .”
Ray Page , D . O ., Ph . D . President and Medical Oncologist The Center for Cancer and Blood Disorders
The Opioid Crisis : Potential Impact on Cancer Patients
Unless you live under a rock , you should be aware through media reports over the last year that the United States has an “ Opioid Crisis ” where deaths attributed to opioid overdose have risen dramatically over the last few years .
The reasons behind this are numerous and complex . They range from early and more frequent exposure of narcotics to our children , to easier access for children and close relatives to use opioids not prescribed to them . Furthermore , there can be a component of imprudent use of opioid prescriptions by physicians . However , with current electronic prescription monitoring the “ pill mill ” doctor hardly exists any more , yet doctors of many specialties are under heightened scrutiny by our boarding agencies on prescription habits .
The problem goes beyond doctor prescribing of opioids . In fact , over the last 3 years physician opioid prescriptions have declined dramatically , while at the same time opioid deaths have risen exponentially !! The reason ? The majority of deaths are caused from illegal heroin and IV fentanyl coming from Mexico and China !!! This is not a doctor problem !!!
Regardless , there is a call out to all of our government agencies to “ DO SOMETHING to fix the opioid problem .” What does that usually mean ? More government regulations , whether they make sense or whether there could be significant unintended consequences – particularly for patients that truly need opioids for pain relief – such as cancer patients .
|
|
So , the FDA has proposed a laundry list of ways they think they can better control opioids and they requested comments from the American Society of Clinical Oncology ( ASCO ). My colleague , Dr . Barbara McAneny ( incoming President of the AMA ) and I gave written comments to the FDA for ASCO . |
|
|
|
In the first week of February , representing ASCO , I went to the FDA in Washington , D . C . and got to meet directly with the FDA Opioid Crisis Committee . Along with 4 other fellow oncologists from Indiana , Ohio , California , and Hawaii , we gave strong recommendations for improving regulation , oversight , and education while still protecting patients that truly need opioids for pain control . We explained to the FDA that we want to assure that cancer patients and any person towards the end of life have unencumbered access to opioids through their cancer doctors and physicians providing palliative care . |
|
Schedule appointments by calling 817-596-0637 or online at www . thecentertx . com |
Support services provided by : |
We had a great discussion about their proposed ideas . I expect the FDA will put out a number of new regulations regarding opioid packaging , prescription limits , education , storage and disposal , and electronic reporting , but I believe we will have protections in place for our cancer patients requiring opioids for pain relief .
It is a great honor for me to have the opportunity to represent the interests and protect our cancer patients .
To learn more about cancer care issues or to consult with a physician about a cancer diagnosis , contact us at 817.596.0637 .
|
MARCH 2018 PARKER COUNTY TODAY |
|
|
|
37 |
The Opioid Crisis:
Potential Impact on Cancer Patients
“There is nothing more important to me
as a physician than your cancer treatment.
I’ve been in practice for over two
decades and have had the privilege of
telling many patients that there is life
beyond cancer. As president of The Center
for Cancer and Blood Disorders, I want to
lead by example, practicing a firm belief
that all patients should receive the finest
medical care available, with the same
concern and compassion as a cherished
member of the family.”
Ray Page, D.O., Ph.D.
President and Medical Oncologist
The Center for Cancer and Blood Disorders
Unless you live under a rock, you should be aware through media
reports over the last year that the United States has an “Opioid Crisis”
where deaths attributed to opioid overdose have risen dramatically
over the last few years.
The reasons behind this are numerous and complex. They range from
early and more frequent exposure of narcotics to our children, to
easier access for children and close relatives to use opioids not
prescribed to them. Furthermore, there can be a component of
imprudent use of opioid prescriptions by physicians. However, with
current electronic prescription monitoring the “pill mill” doctor
hardly exists any more, yet doctors of many specialties are under
heightened scrutiny by our boarding agencies on prescription habits.
The problem goes beyond doctor prescribing of opioids. In fact, over
the last 3 years physician opioid prescriptions have declined
dramatically, while at the same time opioid deaths have risen
exponentially!! The reason? The majority of deaths are caused from
illegal heroin and IV fentanyl coming from Mexico and China!!! This
is not a doctor problem!!!
Regardless, there is a call out to all of our government agencies to
“DO SOMETHING to fix the opioid problem.” What does that usually
mean? More government regulations, whether they make sense or
whether there could be significant unintended consequences –
particularly for patients that truly need opioids for pain relief – such
as cancer patients.
So, the FDA has proposed a laundry list of ways they think they can
better control opioids and they requested comments from the
American Society of Clinical Oncology (ASCO). My colleague,
Dr. Barbara McAneny (incoming President of the AMA) and I gave
written comments to the FDA for ASCO.
In the first week of February, representing ASCO, I went to the FDA in
Washington, D.C. and got to meet directly with the FDA Opioid Crisis
Committee. Along with 4 other fellow oncologists from Indiana, Ohio,
California, and Hawaii, we gave strong recommendations for
improving regulation, oversight, and education while still protecting
patients that truly need opioids for pain control. We explained to
the FDA that we want to assure that cancer patients and any person
towards the end of life have [�[��[X�\�YX��\����[�Y���Y��Z\��[��\���ܜ�[�\�X�X[���ݚY[��[X]]�H�\�K����Y[H\�[�Y[���H�[[�M�MNM�L
���܈ۛ[�H]���˝X�[�\����B��\ܝ�\��X�\��ݚYY�N���X\��[ܙHX��]�[��\��\�H\��Y\�܈��ۜ�[�]H\�X�X[��X��]H�[��\�XYۛ��\��X�\�]MˍNM��
��˂�]\�HܙX]ۛ܈�܈YH�]�HH�ܝ[�]H��\�\�[�B�[�\�\��[���X��\��[��\�]Y[�˂��HYHܙX]\��\��[ۈX��]Z\�����YYX\ˈH^X�B��H�[]�]H�[X�\�و�]��Y�[][ۜ��Y�\�[���[�Y�X��Y�[���\�ܚ\[ۈ[Z]�YX�][ۋ�ܘY�H[�\���[[��[X��ۚX��\ܝ[���]H�[Y]�H�H�[]�H��X�[ۜ�[�X�H�܂��\��[��\�]Y[���\]Z\�[���[�Y��܈Z[��[YY����